mifepristone has been researched along with Affective Disorders, Psychotic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbero, JD; Bioque, M; Cobo, J; García-Rizo, C; González-Rodríguez, A; Huerta-Ramos, E; Labad, J; Monreal, JA; Soria, V; Tost, M; Usall, J | 1 |
| Howland, RH | 1 |
| Schatzberg, AF | 1 |
| Rothschild, AJ | 2 |
| El Sheshai, A; Fawzy, W; Fayek, M; Kingsbury, SJ; Loza, N; Rady, A; Simpson, GM | 1 |
| Carroll, BJ; Rubin, RT | 1 |
3 review(s) available for mifepristone and Affective Disorders, Psychotic
| Article | Year |
|---|---|
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
Topics: Affective Disorders, Psychotic; Bipolar Disorder; Cognition Disorders; Cognitive Dysfunction; Depressive Disorder, Major; Female; Gonadal Steroid Hormones; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mifepristone; Mood Disorders; Pituitary-Adrenal System; Pregnenolone; Raloxifene Hydrochloride; Schizophrenia | 2018 |
Mifepristone as a therapeutic agent in psychiatry.
Topics: Affective Disorders, Psychotic; Alcoholism; Antipsychotic Agents; Clinical Trials as Topic; Cocaine-Related Disorders; Hormone Antagonists; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Mental Disorders; Mifepristone; Pituitary-Adrenal System; Psychotic Disorders; Stress Disorders, Post-Traumatic; Weight Gain | 2013 |
New approaches to managing psychotic depression.
Topics: Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium; Mifepristone; Olanzapine; Pirenzepine; Receptors, Glucocorticoid; Treatment Outcome | 2003 |
1 trial(s) available for mifepristone and Affective Disorders, Psychotic
| Article | Year |
|---|---|
An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mifepristone; Progesterone; Psychiatric Status Rating Scales; Receptors, Glucocorticoid; Treatment Outcome | 2005 |
3 other study(ies) available for mifepristone and Affective Disorders, Psychotic
| Article | Year |
|---|---|
Conflict-of-interest charge.
Topics: Affective Disorders, Psychotic; Book Reviews as Topic; Conflict of Interest; Depressive Disorder; Disclosure; Humans; Mifepristone; Scientific Misconduct; Treatment Outcome | 2004 |
Placebo response in psychotic depression.
Topics: Affective Disorders, Psychotic; Brief Psychiatric Rating Scale; Depressive Disorder, Major; Hormone Antagonists; Humans; Mifepristone; Placebo Effect; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Severity of Illness Index; Treatment Outcome | 2005 |
Is mifepristone useful in psychotic depression?
Topics: Adrenocorticotropic Hormone; Affective Disorders, Psychotic; Antidepressive Agents; Clinical Trials as Topic; Data Interpretation, Statistical; Depressive Disorder; Hormone Antagonists; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Mifepristone; Patient Selection; Receptors, Glucocorticoid; Reproducibility of Results; Treatment Outcome | 2006 |